Document is current
Any future updates will be listed below
-
Authors
Li, Jian-wei
Zuo, Wen-jia
Ivanova, Diana
Jia, Xiao-qing
Lei, Li
Liu, Guang-yu http://orcid.org/0000-0001-5464-4395
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct01924078 at ClinicalTrials.govDocuments that mention this clinical trial
Metronomic capecitabine combined with aromatase inhibitors for new chemoendocrine treatment of advanced breast cancer: a phase II clinical trial
https://doi.org/10.1007/s10549-018-5024-3
- License Information
-
More Information
Article History
Received: 4 September 2018
Accepted: 20 October 2018
First Online: 25 October 2018
Compliance with ethical standards
:
: The authors declare no conflicts of interests.
: This study was approved by an independent ethics committee at FUSCC. Written informed consent was obtained from all patients before enrollment in the study. The clinical trial complies with the current laws of China.
